BCAB Earnings

Quarterly EPS
$-11.00
Q3 2024
$-14.99
Q4 2024
$-13.16
Q1 2025
$-15.99
Q2 2025
$-13.50
Q3 2025
$-2.81
Q4 2025
$-4.22
Q1 2026
$0.27
Q2 2026
Latest Revenue6.5M
Latest Net Income452.0K
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.276.5M452.0K+101.7%
Q1 2026-$4.220-6344000+67.9%
Q4 2025-$2.812.0M-9784000+81.3%
Q3 2025-$13.500-15778000-100.0%-22.7%
Q2 2025-$15.990-18711000+27.3%
Q1 2025-$13.160-15334000+45.2%
Q4 2024-$14.990-14884000+46.6%
Q3 2024-$11.0011.0M-10586000+68.6%
Q2 2024-$22.000-21072000
Q1 2024-$24.000-23234000
Q4 2023-$28.050-26925000
Q3 2023-$35.000-33325000
BioAtla (BCAB) — Earnings